NextMeds review
NextMeds is a compounded-GLP-1 telehealth platform naming a real clinical group (Lion MD, led by two NPI-verifiable physicians) and six named compounding pharmacies — unusually transparent on that front.
- Semaglutide
- $79/mo (starting dose, promotional rate, compounded)
- Tirzepatide
- $129/mo (starting dose, promotional rate, compounded)
- Coverage
- All 50 states
- Brand-name
- Compounded only
Semaglutide · modeled / year
$948
Tirzepatide · modeled / year
$1,548
Pricing verified August 2026
The Index scorecard
NextMeds scored on our six Cost-Efficiency Index factors. See the methodology.
Where the value is
- Names a real, NPI-verifiable clinical group (Lion MD: Dr. Ana Lisa Carr, Dr. Kelly Tenbrink) rather than an anonymous provider network
- Names six real compounding pharmacies (Belmar, Strive, Epiq Scripts, Casa Pharma Rx, The Pharmacy Hub, Foothills) instead of one generic claim
- Claims and states 'We service all 50 states'
- 1:1 care coach and licensed registered nutritionist bundled into every plan per the site
The tradeoffs
- The live site shows at least three different headline promo prices ($69/$79/$89 for semaglutide) concurrently or near-concurrently, with no clear single 'current' number — a real transparency problem
- Aggressive countdown-timer urgency tactics ('Price increases in...', 'OFFER ENDS AUGUST 10TH AT MIDNIGHT!') are used to pressure signup
- The LegitScript badge links only to a generic verify page, not a distinct certification ID I could independently confirm
- Compounded GLP-1s are not FDA-reviewed or approved — a different regulatory tier than brand-name
The bottom line
Best for: Shoppers who will call out and verify the exact price at checkout, given the site shows several different promo numbers at once. NextMeds is a compounded-GLP-1 telehealth platform naming a real clinical group (Lion MD, led by two NPI-verifiable physicians) and six named compounding pharmacies — unusually transparent on that front.
Ranked #61 of 539 providers on the Cost-Efficiency Index — see our #1 pick, CoreAge Rx, for comparison.
Compare with other providers
All 538 other providers we've modeled, in Cost-Efficiency Index order. See the ranked alternatives to NextMeds.
- #50NiceRx— NiceRx is a compounded GLP-1 telehealth platform charging $199/mo for semaglutide and $299/mo for tirzepatide on an ongoing month-to-month basis (first month discounted to $99 and $199 respectively).76/100
- #51Vytora Health— Vytora Health (Wasef Health, PC) is a 50-state-plus-DC telehealth platform selling flat-rate compounded semaglutide and tirzepatide alongside retail-priced brand-name Mounjaro and Zepbound ($1,399/mo each).76/100
- #52Rylo Health— Rylo Health is a compounded GLP-1/NAD+/peptide telehealth platform operating in all 50 states through Lone Star Virtual Health PLLC and dispensing via VialsRX in Houston, TX.75/100
- #53Synergy Rx— Brand Wegovy, Ozempic or Mounjaro when clinically appropriate, with unlimited round-the-clock clinical contact — at prices its own site never shows.72/100
- #54Peter MD— One account across six verticals — TRT, ED, weight loss, GLP-1, men's hair loss and NAD+ — from a physician-prescribed telehealth brand running since 2021, at a renewal price ($249/mo tirzepatide) well above its own $149 first-month headline.72/100
- #55EdgeRx— The best clinical documentation of any newly added row — a named Chief Medical Advisor and a named 503A pharmacy — but it's a men's-only platform, not a fit for every reader.74/100
The 24 programs nearest this one
- #62 Science & Co74
- #63 Gala Health71
- #64 Direct Meds71
- #65 He & She MD71
- #66 SkinnyRx71
- #67 Amazon One Medical73
- #68 MyFastRx73
- #69 Navio MD73
- #70 Ozari Health73
- #71 Trillium Meds73
- #72 Clume Health73
- #73 BiltRx72
- #74 Candor Rx72
- #75 Get Thin MD72
- #76 Heally72
- #77 Recovery Delivered72
- #78 Nova72
- #79 Bodybuilding Health+69
- #80 Apex MD71
- #81 GOAL.MD71
- #82 Queen RX71
- #83 Rivo Health71
- #84 Goldspan Health71
- #85 altRX70
Pricing, states and verification reflect NextMeds's public disclosures at last review; the Cost-Efficiency Index is our editorial judgment per the methodology. Prices change — confirm on NextMeds's site. Not medical advice; see our disclosure.